Cost-Based Pricing to Hit Exports, Says Indian Pharmaceutical Alliance

The Indian Pharmaceutical Alliance says the export earnings of the manufacturers will be hit if the government continues with the cost-based pricing mechanism under the proposed drug policy.
The Economic Times